The Semaglutide Report

Is WEGOVY covered by insurance?

Sometimes, and what decides it is the reason on the prescription rather than the drug. WEGOVY’s label carries three approved uses, and a plan pays against one of them. On Medicare, a federal program has covered it at $50 a month since July.1,5

On this page

Coverage follows the indication, not the molecule

A drug list does not have a line for “semaglutide.” It has lines for named products, each attached to the reason a prescriber wrote it. WEGOVY’s label carries three reasons, and the first, for the injection, reads:

to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight.

WEGOVY prescribing information, section 1. 1

The second is weight reduction, in adults with obesity or with overweight and a weight-related condition, and in children aged 12 and over with obesity. The third is a liver condition, noncirrhotic MASH with moderate to advanced fibrosis. WEGOVY tablets carry the first two. All of them are indicated “in combination with a reduced calorie diet and increased physical activity.”1

That matters because plans that exclude weight-loss drugs as a benefit category may still cover the same product written for cardiovascular risk reduction. What your plan is deciding, lever by lever, is on what decides whether a plan covers semaglutide. The question to settle first is which indication your prescription names.

On Medicare: the GLP-1 Bridge, since 1 July 2026

Medicare opened a program this summer that pays for WEGOVY directly, outside your drug plan’s own formulary.

Starting July 1, 2026, Medicare has a new program called Medicare GLP-1 Bridge to help you pay for certain GLP-1 weight loss medicines.

Medicare GLP-1 Bridge fact sheet, What You Need to Know for July 1, 2026. 5

WEGOVY is on its list, in both forms. So are Foundayo tablets and the Zepbound KwikPen, and the fact sheet says single-dose Zepbound pens and vials are not covered. The price is the same whatever you earn:5

Your cost for these drugs under this program is $50 per month, no matter your income level. This $50 payment doesn’t count toward your Medicare drug plan deductible or yearly out-of-pocket limit.

Medicare GLP-1 Bridge fact sheet, What You Need to Know for July 1, 2026. 5
All four have to be true to get WEGOVY through Medicare GLP-1 Bridge.
The requirementWhat it means
Part DYou have Medicare Part D drug coverage, through a standalone drug plan or a Medicare health plan that includes drug coverage.
Not already coveredYou are not eligible to receive a GLP-1 drug through your Medicare drug plan. If your plan already pays for one, you keep getting it that way.
Three conditionsYou do not have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. The fact sheet says to contact your drug plan if you do, because it may already cover a GLP-1 for you.
Age and BMIYou are 18 or older, and your BMI is 35 or higher; or 30 or higher with certain heart failure, hard-to-control high blood pressure or chronic kidney disease (stage 3a or above); or 27 or higher with prediabetes, or a previous heart attack, stroke or blocked arteries in the legs or arms.

Medicare GLP-1 Bridge fact sheet, CMS Product No. 12234, June 2026, under “Am I eligible?”. Condensed from the fact sheet’s own four checkboxes; it is listed under Sources.

Your prescriber sends the prescription and a form. Medicare.gov says the approval holds for a while:

Your prior authorization is valid (including for refills and dose changes) through December 31, 2027, unless you change GLP-1s.

Medicare.gov, Weight loss drugs, Provider requirements. 4

On an employer or Marketplace plan

Here there is no single answer, and the useful thing is to find out which kind of no you have. HealthCare.gov lists seven grounds a plan can deny on. Two of them land on this drug: that the benefit is not offered under your health plan, and that the treatment is “not medically necessary.”3

They are not the same problem. The first is about what your employer bought, and more clinical documentation will not move it. The second is the one a prescriber’s submission can answer, and it is the one with published deadlines on both sides. Prior authorization, and the appeal has the route, the documents and the clocks.

Get the refusal in writing before you argue with it. A denial letter names the ground; a phone call does not, and nothing you can appeal starts until the letter exists.

What to ask, in one call

Ask for the answer by product and by indication, in that order: whether the plan covers WEGOVY, whether it covers it for the indication on your prescription, what tier it sits on, and what it requires before it pays. Ask for the prior authorization criteria by name, and ask for them in writing. When comparing a care program as well as a drug benefit, the LifeMD review distinguishes program charges from the medication route.

If the answer is that there is no benefit at all, the next question is what the drug costs without one. What the WEGOVY pen costs and what the pill costs have the maker’s own self-pay prices, and what semaglutide costs by dose has what the telehealth market publishes.

Questions

Does insurance cover WEGOVY for weight loss?

Some plans do and some exclude weight-loss drugs as a category. The label approves WEGOVY for weight reduction, for cardiovascular risk reduction and for a liver condition, and a plan can treat those differently, so the answer turns on which one your prescription is written for.

Will Medicare pay for WEGOVY?

Through the Medicare GLP-1 Bridge program, yes, if you qualify: $50 a month since 1 July 2026, for eligible Part D enrollees who are not already getting a GLP-1 through their drug plan and who meet the age and BMI requirements. Your prescriber submits a prior authorization, and it runs through 31 December 2027.5

My plan said no. Is that the end of it?

It depends which no it is. If the benefit is not offered under the plan, documentation will not change it, and the question becomes what the drug costs without insurance. If the plan called the treatment not medically necessary, that is what an appeal is for, and the deadlines are published.

Is compounded semaglutide covered instead?

That is a separate question with a separate answer, and a compounded preparation is not the approved product a formulary lists. Is compounded semaglutide covered by insurance sets out what to ask.

Sources

  1. WEGOVY- semaglutide injection, solution; WEGOVY- semaglutide tablet

    DailyMed, U.S. National Library of Medicine. Updated June 18, 2026 — label Revised: 6/2026.

  2. OZEMPIC- semaglutide injection, solution

    DailyMed, U.S. National Library of Medicine. Updated June 1, 2026 — label Revised: 5/2026.

  3. Internal appeals

    HealthCare.gov, Centers for Medicare & Medicaid Services.

  4. Weight loss drugs

    Medicare.gov, Centers for Medicare & Medicaid Services.

  5. Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month (fact sheet)

    Centers for Medicare & Medicaid Services. CMS Product No. 12234 · June 2026.

A reference, not medical advice, and not a substitute for your prescriber or pharmacist. It is not insurance advice either: only your plan’s own documents and your plan’s own staff can tell you what it covers. If you think you are having a medical emergency, call your local emergency number.